Praziquantel
- Generic Name
- Praziquantel
- Brand Names
- Biltricide
- Drug Type
- Small Molecule
- Chemical Formula
- C19H24N2O2
- CAS Number
- 55268-74-1
- Unique Ingredient Identifier
- 6490C9U457
- Background
An anthelmintic used in most schistosome and many cestode infestations.
- Indication
For the treatment of infections due to all species of schistosoma.
- Associated Conditions
- Cestode infections, Cysticercosis, Liver fluke infection, Trematode infections, Schistosoma infection
- Associated Therapies
- -
Schistosoma Haematobium Infections and Praziquantel
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2013-01-17
- Lead Sponsor
- University of Khartoum
- Target Recruit Count
- 520
- Registration Number
- NCT01558336
- Locations
- 🇸🇩
Al Salamania, Al Salamania, Nile, Sudan
Praziquantel-Pharmacokinetic Study
- First Posted Date
- 2011-02-03
- Last Posted Date
- 2019-01-18
- Target Recruit Count
- 47
- Registration Number
- NCT01288872
- Locations
- 🇵🇭
Research Institute for Tropical Medicine - Health Compound, Muntinlupa City, National Capital Region, Philippines
Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa
- Conditions
- Interventions
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 6500
- Registration Number
- NCT01154907
- Locations
- 🇿🇦
University of KwaZulu Natal, Durban, KwaZulu Natal, South Africa
A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni
- Conditions
- Interventions
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2010-01-22
- Lead Sponsor
- Kenya Medical Research Institute
- Target Recruit Count
- 212
- Registration Number
- NCT01054651
- Locations
- 🇰🇪
KEMRI Centre for Global Health Research, Kisumu, Kenya
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
- Conditions
- First Posted Date
- 2007-08-01
- Last Posted Date
- 2008-01-18
- Lead Sponsor
- Dafra Pharma
- Target Recruit Count
- 800
- Registration Number
- NCT00510159
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
- Conditions
- Interventions
- First Posted Date
- 2007-07-26
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 948
- Registration Number
- NCT00507221
- Locations
- 🇰🇪
Kenya Medical Research Institute, Nairobi, Kenya
S. Japonicum and Pregnancy Outcomes
- First Posted Date
- 2007-06-15
- Last Posted Date
- 2016-01-26
- Target Recruit Count
- 370
- Registration Number
- NCT00486863
- Locations
- 🇵🇭
Research Institute for Tropical Medicine - Health Compound, Muntinlupa City, National Capital Region, Philippines
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
- Conditions
- Interventions
- First Posted Date
- 2007-02-28
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Universidad Peruana Cayetano Heredia
- Target Recruit Count
- 156
- Registration Number
- NCT00441285
- Locations
- 🇵🇪
Universidad Peruana Cayetano Heredia, Lima, Peru
🇵🇪Hospital Nacional Edgardo Rebagliati, Lima, Peru
🇵🇪Hospital Nacional Cayetano Heredia, Lima, Peru
Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
- Conditions
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2007-04-20
- Target Recruit Count
- 520
- Registration Number
- NCT00231322
- Locations
- 🇲🇿
Matola, Maputo, Maputo Province, Mozambique
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2008-02-21
- Target Recruit Count
- 540
- Registration Number
- NCT00215267
- Locations
- 🇺🇬
Musoli village, Busuyi parish, Mayuge District, Uganda
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.